LSL Pharma Group Inc. (TSXV:LSL)
Canada · Delayed Price · Currency is CAD 0.3500
-0.0050 (-1.41%)
At close: Aug 10, 2026
LSL Pharma Group Market Cap
LSL Pharma Group has a market cap or net worth of CAD 44.99 million as of August 10, 2026. Its market cap has decreased by -5.02% in one year.
Market Cap
44.99M
Enterprise Value
82.79M
Revenue
28.74M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.35
ChartMarket Cap Chart
Since March 2, 2023, LSL Pharma Group's market cap has decreased from 61.67M to 44.99M, a decrease of -27.05%. That is a compound annual growth rate of -8.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 44.99M | 6.04% |
| Dec 31, 2025 | 42.43M | -10.43% |
| Dec 31, 2024 | 47.37M | 18.48% |
| Dec 29, 2023 | 39.98M | -35.17% |
| Mar 2, 2023 | 61.67M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Decibel Cannabis Company | 63.47M |
| Vext Science | 63.16M |
| Planet 13 Holdings | 55.33M |
| BioNxt Solutions | 40.82M |
| C21 Investments | 40.35M |
| ZYUS Life Sciences | 39.86M |
| Optimi Health | 39.51M |
| Rubicon Organics | 37.17M |